Literature DB >> 32588171

Benefits in noise from sound processor upgrade in thirty-three cochlear implant users for more than 20 years.

Isabelle Mosnier1, Olivier Sterkers2, Yann Nguyen2, Ghizlene Lahlou2.   

Abstract

PURPOSE: Some oldest patients rehabilitated with a cochlear implant more than 20 years ago could still be upgraded with new generations of speech processor (SP). The aim of this study was to show the benefit of a recent generation of SP in this population.
METHODS: A monocentric prospective study was designed to evaluate the performance of 33 ancient CI22M users implanted between 1989 and 1997 and upgraded with the late compatible sound processor CP900. Performance was evaluated in quiet and noise with Framatix, an automated adaptative test.
RESULTS: Performance using Framatix significantly improved with the CP900, with a decrease of the median speech perception threshold of 6 dB in quiet (p < 0.05) and 5,3 dB in noise (p < 0.0005). No subjective benefit using the APHAB questionnaire was observed.
CONCLUSION: Upgrading of cochlear implant recipients who were implanted more than 20 years ago with recent compatible and new technological SP provide benefit in speech recognition in noise.

Entities:  

Keywords:  Hearing in noise; Long-term benefit; Speech processor; Upgrading

Year:  2020        PMID: 32588171     DOI: 10.1007/s00405-020-06144-y

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  7 in total

1.  Comparison of three types of French speech-in-noise tests: a multi-center study.

Authors:  Sofie Jansen; Heleen Luts; Kirsten Carola Wagener; Birger Kollmeier; Matthieu Del Rio; René Dauman; Chris James; Bernard Fraysse; Emilie Vormès; Bruno Frachet; Jan Wouters; Astrid van Wieringen
Journal:  Int J Audiol       Date:  2011-11-28       Impact factor: 2.117

2.  Benefit of the UltraZoom beamforming technology in noise in cochlear implant users.

Authors:  Isabelle Mosnier; Nathalie Mathias; Jonathan Flament; Dorith Amar; Amelie Liagre-Callies; Stephanie Borel; Emmanuèle Ambert-Dahan; Olivier Sterkers; Daniele Bernardeschi
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-06-29       Impact factor: 2.503

3.  Benefits from upgrade to the CP810 sound processor for Nucleus 24 cochlear implant recipients.

Authors:  Isabelle Mosnier; Mathieu Marx; Frederic Venail; Natalie Loundon; Samantha Roux-Vaillard; Olivier Sterkers
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-14       Impact factor: 2.503

4.  Long-Term Cognitive Prognosis of Profoundly Deaf Older Adults After Hearing Rehabilitation Using Cochlear Implants.

Authors:  Isabelle Mosnier; Antoine Vanier; Damien Bonnard; Geneviève Lina-Granade; Eric Truy; Philippe Bordure; Benoit Godey; Mathieu Marx; Emmanuel Lescanne; Frédéric Venail; Christine Poncet; Olivier Sterkers; Joël Belmin
Journal:  J Am Geriatr Soc       Date:  2018-08-08       Impact factor: 5.562

Review 5.  Neurocognitive factors in sensory restoration of early deafness: a connectome model.

Authors:  Andrej Kral; William G Kronenberger; David B Pisoni; Gerard M O'Donoghue
Journal:  Lancet Neurol       Date:  2016-03-12       Impact factor: 44.182

6.  The Oticon Medical Neuro Zti cochlear implant and the Neuro 2 sound processor: multicentric evaluation of outcomes in adults and children.

Authors:  Valérie Franco-Vidal; Cécile Parietti-Winkler; Nicolas Guevara; Eric Truy; Natalie Loundon; Sonanda Bailleux; Marine Ardoint; Sonia Saaï; Michel Hoen; Ariane Laplante-Lévesque; Isabelle Mosnier; Philippe Bordure; Christophe Vincent
Journal:  Int J Audiol       Date:  2019-10-04       Impact factor: 2.117

Review 7.  Dementia prevention, intervention, and care.

Authors:  Gill Livingston; Andrew Sommerlad; Vasiliki Orgeta; Sergi G Costafreda; Jonathan Huntley; David Ames; Clive Ballard; Sube Banerjee; Alistair Burns; Jiska Cohen-Mansfield; Claudia Cooper; Nick Fox; Laura N Gitlin; Robert Howard; Helen C Kales; Eric B Larson; Karen Ritchie; Kenneth Rockwood; Elizabeth L Sampson; Quincy Samus; Lon S Schneider; Geir Selbæk; Linda Teri; Naaheed Mukadam
Journal:  Lancet       Date:  2017-07-20       Impact factor: 202.731

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.